Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN™; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts

Kaye J. Williams, B. A. Telfer, A. M. Shannon, M. Babur, I. J. Stratford, S. R. Wedge

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN™; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology